Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 132.50
Bid: 132.50
Ask: 132.65
Change: -1.20 (-0.90%)
Spread: 0.15 (0.113%)
Open: 133.70
High: 134.95
Low: 131.80
Prev. Close: 133.70
CNA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

5 May 2020 14:30

RNS Number : 0022M
Centrica PLC
05 May 2020
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Centrica plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

X

Other (please specify)iii:

3. Details of person subject to the notification obligation

Name

Aggregate of Standard Life Aberdeen plc affiliated investment management entities with delegated voting rights on behalf of multiple managed portfolios

City and country of registered office (if applicable)

Edinburgh, Scotland

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

01/05/2020

6. Date on which issuer notified (DD/MM/YYYY):

04/05/2020

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

4.99

0.00

4.99

5,837,574,575

Position of previous notification (if

applicable)

5.06

0.00

5.06

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

 

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B033F229

N/A

291,307,238

N/A

4.99

SUBTOTAL 8. A

291,307,238

4.99

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

Exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Standard Life Aberdeen plc

Standard Life Investments (Holdings) Limited

Standard Life Investments Limited

Standard Life Aberdeen plc

Aberdeen Asset Management PLC

Aberdeen Asset Investment Group Limited

Aberdeen Asset Investments Limited

Standard Life Aberdeen plc

Aberdeen Asset Management PLC

Aberdeen Asset Managers Limited

Standard Life Aberdeen plc

Standard Life Investments (Holdings) Limited

Ignis Asset Management Limited

Ignis Investment Services Limited

Standard Life Aberdeen plc

Standard Life Investments (Holdings) Limited

Aberdeen Standard Capital Limited

Aberdeen Standard Capital International Limited

 

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

 

In reference to section 9, the shares detailed are managed by the named discretionary investment management entity within multiple portfolios on behalf of underlying clients, based on investment management agreements whereby the client has delegated the exercise of the voting power to the referenced investment manager.

 

 

 

Place of completion

Aberdeen, United Kingdom

Date of completion

04/05/2020

 

Centrica plc is listed on the London Stock Exchange (CNA)Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654Legal Entity Identifier number: E26EDV109X6EEPBKVH76ISIN number: GB00B033F229

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLSSIFEIESSEII
Date   Source Headline
27th Mar 202312:30 pmRNSDirector/PDMR Shareholding
24th Mar 20236:15 pmRNSTransaction in Own Shares
24th Mar 20235:00 pmRNSHolding(s) in Company
24th Mar 202310:00 amRNSHolding(s) in Company
23rd Mar 20236:00 pmRNSTransaction in Own Shares
22nd Mar 20236:10 pmRNSTransaction in Own Shares
22nd Mar 20233:30 pmRNSDirector/PDMR Shareholding
22nd Mar 202311:19 amRNSAnnual Financial Report 2022
21st Mar 20236:10 pmRNSTransaction in Own Shares
20th Mar 20236:20 pmRNSTransaction in Own Shares
20th Mar 20235:20 pmRNSHolding(s) in Company
17th Mar 20236:15 pmRNSTransaction in Own Shares
16th Mar 20236:00 pmRNSTransaction in Own Shares
16th Mar 20235:00 pmRNSHolding(s) in Company
15th Mar 20236:25 pmRNSTransaction in Own Shares
15th Mar 20234:20 pmRNSHolding(s) in Company
15th Mar 20239:00 amRNSDirector/PDMR Shareholding
14th Mar 20236:20 pmRNSTransaction in Own Shares
14th Mar 20237:00 amRNSPlans to extend life of two nuclear power stations
13th Mar 20236:25 pmRNSTransaction in Own Shares
13th Mar 20232:00 pmRNSDirector/PDMR Shareholding
10th Mar 20236:15 pmRNSTransaction in Own Shares
10th Mar 20233:45 pmRNSHolding(s) in Company
9th Mar 20236:15 pmRNSTransaction in Own Shares
8th Mar 20236:25 pmRNSTransaction in Own Shares
7th Mar 20236:25 pmRNSTransaction in Own Shares
6th Mar 20236:25 pmRNSTransaction in Own Shares
6th Mar 20234:20 pmRNSHolding(s) in Company
6th Mar 202312:50 pmRNSHolding(s) in Company
3rd Mar 20236:25 pmRNSTransaction in Own Shares
2nd Mar 20236:25 pmRNSTransaction in Own Shares
2nd Mar 20233:30 pmRNSHolding(s) in Company
1st Mar 20236:34 pmRNSTransaction in Own Shares
1st Mar 20234:45 pmRNSTotal Voting Rights
28th Feb 20236:15 pmRNSTransaction in Own Shares
28th Feb 202312:15 pmRNSHolding(s) in Company
27th Feb 20236:25 pmRNSTransaction in Own Shares
27th Feb 202312:45 pmRNSCommittee Chair Succession & Director Declaration
27th Feb 202310:30 amRNSDirector/PDMR Shareholding
27th Feb 202310:00 amRNSHolding(s) in Company
24th Feb 20236:29 pmRNSTransaction in Own Shares
23rd Feb 20235:30 pmRNSTransaction in Own Shares
22nd Feb 20235:30 pmRNSTransaction in Own Shares
21st Feb 20235:45 pmRNSTransaction in Own Shares
21st Feb 20232:30 pmRNSDirector/PDMR Shareholding
20th Feb 20235:40 pmRNSTransaction in Own Shares
17th Feb 20235:30 pmRNSTransaction in Own Shares
16th Feb 20235:30 pmRNSTransaction in Own Shares
16th Feb 20237:00 amRNSFinal Results
15th Feb 20235:45 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.